For the reasons previously discussed, we stated in the CY 2026 OPPS/ASC proposed rule that we believe the use of median payer-specific negotiated charge data for a hospital's MAOs, to be collected on the Medicare cost report, may support the development of an appropriate market-based approach to payment under the Medicare FFS system by incorporating such data into the estimation of the relative hospital resources used with respect to discharges classified within a single MS-DRG compared to discharges classified within other MS-DRGs, as required by statute
Its hard to estimate exactly how much Americans needle aversion has tamped down their uptake of GLP-1 drugs
If these persist, consult your doctor
La informacin, permanentemente actualizada, de todos los medicamentos autorizados y controlados por la AEMPS est disponible en la web de la Agencia, www.aemps.gob.es, dentro del apartado Centro de Informacin online de Medicamentos (CIMA)
It's the only one of the two that's also approved to help reduce heart attack and stroke risk in people with obesity or carrying excess weight and who have existing cardiovascular disease
That is why retatrutide titration is slower and more granular than tirzepatide's, and why dose-skipping carries different consequences